Literature DB >> 35702068

Identification of a novel immune gene panel in tongue squamous cell carcinoma.

Jiwei Sun1,2,3, Fengyuan Guo1,2,3, Qingming Tang1,2,3, Guangjin Chen1,2,3, Jinfeng Peng1,2,3, Yufeng Shen1,2,3, Junyuan Zhang1,2,3, Jingqiong Hu4, Cheng Yang1,2,3.   

Abstract

BACKGROUND: Tongue squamous cell carcinoma (TSCC) is one of the most common oral cancers. Immune activity is significantly related to the initiation and progression of TSCC. Systemic analysis of the immunogenomic landscape and identification of crucial immune-related genes (IRGs) would help understanding of TSCC. Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) provide multiple TSCC cases for use in an integrated immunogenomic study.
METHODS: Immune landscape of TSCC was depicted by expression microarray data from GSE13601 and GSE34105. Univariate Cox analysis, in combination with survival analysis, was applied to select candidate IRGs with significant survival value. Survival predicting models were constructed by multivariate Cox regression and logistic regression analysis. Unsupervised clustering analysis was used to construct an immune gene panel based on prognostic IRGs to distinguish TSCC subgroups with different prognostic outcomes. Finally, IHC staining was performed to validate the clinical value of this immune-gene panel.
RESULTS: Differentially expressed IRGs were identified in two TSCC microarray datasets. Functional enrichment analysis revealed that ontology terms associated with variations in T cell function, were highly enriched. Infiltration status of activated CD8+ T cells, central memory CD4+ T cells and type 17 T helper cells, had great prognostic value for TSCC progression. Unsupervised clustering analysis was further performed to classify TSCC patients into three subgroups. CTSG, CXCL13, and VEGFA were finally combined together to form an immune-gene panel, todistinguish different TSCC subgroups. IHC staining of TSCC sections further validated the clinical efficiency of the immune-gene panel consisting of prognostic IRGs to distinguish TSCC patients.
CONCLUSION: VEGFA, CXCL13, and CTSG, correlated with T cell infiltration and prognostic outcome. They were screened to form an immune-gene panel to identify TSCC subgroups with different prognostic outcomes. Clinical IHC further validated the efficacy of this immune-gene panel to evaluate aggressiveness of TSCC development. AJTR
Copyright © 2022.

Entities:  

Keywords:  CTSG; CXCL13; Oral squamous cell carcinoma; VEGFA; immune-related genes; tongue squamous cell carcinoma

Year:  2022        PMID: 35702068      PMCID: PMC9185061     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  48 in total

1.  Global Epidemiology of Head and Neck Cancers: A Continuing Challenge.

Authors:  Bhawna Gupta; Newell W Johnson; Narinder Kumar
Journal:  Oncology       Date:  2016-06-01       Impact factor: 2.935

Review 2.  Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer.

Authors:  Yu Lei; Yuying Xie; Yee Sun Tan; Mark E Prince; Jeffrey S Moyer; Jacques Nör; Gregory T Wolf
Journal:  Oral Oncol       Date:  2016-08-21       Impact factor: 5.337

3.  Classification of tongue cancer resection and treatment algorithm.

Authors:  Giuditta Mannelli; Francesco Arcuri; Tommaso Agostini; Marco Innocenti; Mirco Raffaini; Giuseppe Spinelli
Journal:  J Surg Oncol       Date:  2018-02-12       Impact factor: 3.454

4.  Profiles of immune cell infiltration and their clinical significance in head and neck squamous cell carcinoma.

Authors:  Yu Jin; Xing Qin
Journal:  Int Immunopharmacol       Date:  2020-03-04       Impact factor: 4.932

Review 5.  Mouse Models for Studying Oral Cancer: Impact in the Era of Cancer Immunotherapy.

Authors:  J J Luo; C D Young; H M Zhou; X J Wang
Journal:  J Dent Res       Date:  2018-04-12       Impact factor: 6.116

Review 6.  Immune suppression and reversal of the suppressive tumor microenvironment.

Authors:  Kanako Shimizu; Tomonori Iyoda; Masahiro Okada; Satoru Yamasaki; Shin-Ichiro Fujii
Journal:  Int Immunol       Date:  2018-09-25       Impact factor: 4.823

Review 7.  Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Alhadi Almangush; Ilkka Heikkinen; Antti A Mäkitie; Ricardo D Coletta; Esa Läärä; Ilmo Leivo; Tuula Salo
Journal:  Br J Cancer       Date:  2017-07-27       Impact factor: 7.640

8.  Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells.

Authors:  Madleen Giese; Nadine Turiello; Nicole Molenda; David Palesch; Annika Meid; Roman Schroeder; Paola Basilico; Charaf Benarafa; Marc-Eric Halatsch; Michal Zimecki; Mike-Andrew Westhoff; Christian Rainer Wirtz; Timo Burster
Journal:  Oncotarget       Date:  2016-11-15

9.  STING agonist promotes CAR T cell trafficking and persistence in breast cancer.

Authors:  Nuo Xu; Douglas C Palmer; Alexander C Robeson; Peishun Shou; Hemamalini Bommiasamy; Sonia J Laurie; Caryn Willis; Gianpietro Dotti; Benjamin G Vincent; Nicholas P Restifo; Jonathan S Serody
Journal:  J Exp Med       Date:  2021-02-01       Impact factor: 14.307

10.  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.

Authors:  David A Barbie; Pablo Tamayo; Jesse S Boehm; So Young Kim; Susan E Moody; Ian F Dunn; Anna C Schinzel; Peter Sandy; Etienne Meylan; Claudia Scholl; Stefan Fröhling; Edmond M Chan; Martin L Sos; Kathrin Michel; Craig Mermel; Serena J Silver; Barbara A Weir; Jan H Reiling; Qing Sheng; Piyush B Gupta; Raymond C Wadlow; Hanh Le; Sebastian Hoersch; Ben S Wittner; Sridhar Ramaswamy; David M Livingston; David M Sabatini; Matthew Meyerson; Roman K Thomas; Eric S Lander; Jill P Mesirov; David E Root; D Gary Gilliland; Tyler Jacks; William C Hahn
Journal:  Nature       Date:  2009-10-21       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.